Obermatt

Apollo Hospitals Enterprise

NSI:APOLLOHOSP · INE437A01024
Health Care Providers & ServicesX-Large

360

52
EV / EBIT12
Price / Owner Earnings8
Owner Earnings Yield33
Dividend Yield45
Price/Sales20
EV / Gross Profit20
Price/Book1
Return on Capital83
Cash Return on Capital60
Return on Equity89
EBIT Margin55
Gross Profitability91
Cash Conversion31
Owner Earnings Margin37
Sales growth94
Profit Growth88
Long-Term EPS Growth98
Reinvestment33
Price momentum73
Debt load19
Refinancing57
Debt Payback49
Liquidity45
Analyst ratings80
Opinion Changes50
Price Target Upside13
Market mood81
Value Creation17/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Apollo Hospitals Enterprise generates returns well above its cost of capital, the foundation of durable shareholder value.

Based on 3/5 components.

Profile

CountryIndia
IndustryHealth Care Providers & Services
SizeX-Large
TypePublic Company
ExchangeNSEI
Founded1979
Employees10,419
ISININE437A01024
Last UpdateApr 2, 2026
Themes
NephrologyHealth DiagnosticsUrologyCardiovascularOncologyNeurologyDentistryOrthopaedicsGastroenterologyPulmonologyHealth CareMedical

Description

Apollo Hospitals Enterprise Limited operates within a diversification of markets and sectors, emphasizing its vigorous commitment to health, safety, and environmental standards while achieving high operational efficiencies and sustainable practices.…

Analysis

Hope premium

Apollo Hospitals Enterprise Limited is priced well ahead of what the underlying numbers justify, a pattern we describe as a hope premium. Worth noting: the cash the business generates has lagged behind what the income statement shows.

On valuation, the picture is expensive. The owner-earnings multiple stands at 131.1×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 32% a year, against analyst forecasts of 30%. The price, in other words, assumes less than the experts do.

Growth is solid; the safety picture is sturdy. The company scores 17/20 on our value-creation score: strong value creator. Analyst sentiment is cautious.

Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
71
2023202420252026

All-time high

71

Jun 2026

All-time low

31

Jan 2025

Average rank

55

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
20
39
42
36
Price/Earnings
7
13
5
7
Price/Book
1
5
5
9
Dividend Yield
45
28
24
25
Value (overall)
7
17
8
11

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Apollo Hospitals Enterprise with its peers
Hapvida Participações e Investimentos
SAO:HAPV3
22
CountryBrazil
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Metro Healthcare Indonesia
JKT:CARE
21
CountryIndonesia
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →
Netcare
JNB:NTC
87
CountrySouth Africa
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Sarana Meditama Metropolitan
JKT:SAME
10
CountryIndonesia
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →
Fleury
SAO:FLRY3
95
CountryBrazil
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Bangkok Dusit Medical Services
SET:BDMS
91
CountryThailand
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →